The implant has already received approval from the US Food and Drug Administration. -- ST PHOTO: DESMOND FOO
SINGAPORE (The Straits Times/ANN): Instead of receiving uncomfortable eye injections around once a month for a disease that can lead to blindness, patients may soon have an easier alternative.
A new innovation will allow them to be treated for neovascular age-related macular degeneration (nAMD) twice a year via an implant the size of a rice grain.
